Doorgaan naar hoofdnavigatie Doorgaan naar zoeken Ga verder naar hoofdinhoud

Minimal Residual Disease-Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials

  • International Independent Team for Endpoint Approval of Myeloma Minimal Residual Disease (i2TEAMM) Group
  • , Qian Shi
  • , Bruno Paiva
  • , Levi D Pederson
  • , Natalie Dimier
  • , Ela Talpes
  • , Thomas J Prior
  • , Alberto Orfao
  • , Philippe Moreau
  • , Pieter Sonneveld
  • , Shaji K Kumar
  • , Jesse G Dixon
  • , Reshma Patel
  • , Blake J Bartlett
  • , Jordan Schecter
  • , Phillip McCarthy
  • , Dirk Hose
  • , Anja Seckinger
  • , D'Agostino Mattia
  • , Hartmut Goldschmidt
    • Stefania Oliva, Roger G Owen, Kenneth C Anderson, Jesús San-Miguel, Brian G M Durie, Nikhil Munshi

Onderzoeksoutput: Article › peer review

36 Citaten (Scopus)

Vingerafdruk

Duik in de onderzoeksthema's van 'Minimal Residual Disease-Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials'. Samen vormen ze een unieke vingerafdruk.
Sorteer per

Medicine and Dentistry